Přejít k hlavnímu obsahu

Jorda Radek

Journals

KOVALOVA, M., J. BARAKA, V. MIK, R. JORDA, M. LUO, H. SHAO, V. KRYŠTOF
A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022). Expert Opinion on Therapeutic Patents. 2023, 33(2), 67-87, ISSN: 1354-3776, PMID: 36975020,
KOVALOVA, M., L. HAVLICEK, S. DJUKIC, J. SKERLOVA, M. PERINA, T. POSPÍŠIL, E. ŘEZNÍČKOVÁ, P. ŘEZÁČOVÁ, R. JORDA, V. KRYŠTOF
Characterization of new highly selective pyrazolo[4,3-d]pyrimidine inhibitor of CDK7. Biomedicine & Pharmacotherapy. 2023, 161, 114492, ISSN: 0753-3322, PMID: 36931035,  PDF.
Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines. Investigational New Drugs. 2023, 41(2), 210-219, ISSN: 0167-6997, PMID: 36913160,